-
Venezuela's Machado vows to make Nobel Peace Prize ceremony
-
Kidnapping fears strain family bonds in Nigeria
-
'Chosen' Mbappe on way to making Real Madrid history like Ronaldo: Alonso
-
Russian strikes on Ukraine trigger heating, water cuts
-
Mediators Qatar, Egypt call for next steps in Gaza truce
-
Olympic favourite Malinin pulls off stunning GP Final win
-
Venezuela's Machado to receive peace prize in Oslo: Nobel Institute
-
Russell tops practice times to outpace title-chasing trio
-
India bowl out South Africa for 270 after De Kock ton
-
England staring down the barrel under Gabba lights as Australia dominate
-
Egyptian actor faces challenge in iconic role of singer Umm Kulthum
-
Chock and Bates win Grand Prix Final ice dance
-
Starvation fears as flood toll passes 900 in Indonesia
-
Four civilians, soldier killed in Afghan-Pakistan border clash
-
Milan-Cortina chief admits venue time pinch as Olympic torch relay begins
-
England make quick start after Australia take big lead at Gabba
-
Finally! India break toss jinx as Rahul gets lucky
-
Will EU give ground on 2035 combustion-engine ban?
-
England nemesis Starc stretches Australia lead in Gabba Ashes Test
-
Banana skin 'double whammy' derails McIlroy at Australian Open
-
Epic Greaves double ton earns West Indies draw in first NZ Test
-
Thunder roll to 14th straight NBA win, Celtics beat depleted Lakers
-
Myanmar citizens head to early polls in Bangkok
-
Starvation fears as more heavy rain threaten flood-ruined Indonesia
-
Sri Lanka unveils cyclone aid plan as rains persist
-
Avatar 3 aims to become end-of-year blockbuster
-
Contenders plot path to 2026 World Cup glory after Trump steals show at draw
-
Greaves leads dramatic West Indies run chase in NZ Test nail-biter
-
World record-holders Walsh, Smith grab wins at US Open
-
Ukraine, US to meet for third day, agree 'real progress' depends on Russia
-
Double wicket strike as New Zealand eye victory over West Indies
-
Ayrmid Reports Promising New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
-
Shinoda Dental Named Official Distributor of VHF Milling Machines, Strengthening Its Position in Digital Dentistry
-
Califf Surveying Becomes Leading Supplier of Leica Total Stations in Asia
-
New Memoir In Pursuit of Glory Exposes the High-Stakes Journey to from Laborer to Executive Leadership in a Male-Dominated Industry
-
Peace medal and YMCA: Trump steals the show at World Cup draw
-
NBA legend Jordan in court as NASCAR anti-trust case begins
-
How coaches reacted to 2026 World Cup draw
-
Glasgow down Sale as Stomers win at Bayonne in Champions Cup
-
Trump takes aim at Europe in new security strategy
-
Witness in South Africa justice-system crimes probe shot dead
-
Tuchel urges England not to get carried away plotting route to World Cup glory
-
Russian ambassador slams EU frozen assets plan for Ukraine
-
2026 World Cup draw is kind to favorites as Trump takes limelight
-
WHO chief upbeat on missing piece of pandemic treaty
-
US vaccine panel upends hepatitis B advice in latest Trump-era shift
-
Ancelotti says Brazil have 'difficult' World Cup group with Morocco
-
Kriecmayr wins weather-disrupted Beaver Creek super-G
-
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
-
Mixed day for global stocks as market digest huge Netflix deal
| RBGPF | 0% | 78.35 | $ | |
| BCC | -1.66% | 73.05 | $ | |
| CMSD | -0.3% | 23.25 | $ | |
| BCE | 1.4% | 23.55 | $ | |
| SCS | -0.56% | 16.14 | $ | |
| JRI | 0.29% | 13.79 | $ | |
| NGG | -0.66% | 75.41 | $ | |
| CMSC | -0.21% | 23.43 | $ | |
| RYCEF | -0.34% | 14.62 | $ | |
| RELX | -0.55% | 40.32 | $ | |
| RIO | -0.92% | 73.06 | $ | |
| VOD | -1.31% | 12.47 | $ | |
| AZN | 0.17% | 90.18 | $ | |
| GSK | -0.33% | 48.41 | $ | |
| BTI | -1.81% | 57.01 | $ | |
| BP | -3.91% | 35.83 | $ |
Strive Pharmacy Expands Footprint with Acquisition of Alachua Facility and New Tampa Location, Cementing Leadership in Patient-Focused Compounding Innovation
With more than 700,000 square feet of advanced operations within the next 12 months, Strive solidifies its position as a national leader in pharmaceutical compounding while pursuing its mission to elevate patient care through innovation, scale, and quality.
GILBERT, AZ / ACCESS Newswire / November 4, 2025 / Strive Pharmacy, a leader in personalized healthcare solutions, today announced a significant milestone in its ongoing expansion and mission to redefine what's possible in pharmaceutical compounding with the acquisition of a state-of-the-art manufacturing facility in Alachua, FL., and the expansion of Strive's Tampa operations. These moves reflect the company's continued dedication to growth, innovation, and its core philosophy to NEVER SETTLE.
With these and other initiatives in development, Strive will operate over 700,000 square feet of combined facilities, making it the largest and most advanced compounding pharmacy network in the nation and positioned to support various needs that meet the industry's growing demand for quality compounded medications at scale.
The newly acquired 275,000-square-foot Current Good Manufacturing Practice (CGMP) facility in Alachua has high-tech production, fulfillment, and other drug manufacturing capabilities, including biologics and API. With major pharmaceutical manufacturing companies valuing the facility at upwards of $500M, Strive intends to transform it into the leading 503B outsourcing and contract manufacturing site within the next 12-18 months. Once operational, the site will significantly expand Strive's ability to deliver high-quality therapeutics through multiple channels while maintaining the company's gold-standard commitment to quality.
"This facility represents more than just growth; it's an investment in the future of patient access and pharmaceutical excellence," said Nate Hill, CEO and co-founder of Strive Pharmacy. "The Alachua site will position Strive at the forefront of innovation, allowing us to serve providers and patients on a broader scale while maintaining the precision, quality, and care that define who we are."
At the same time, Strive has completed the expansion and transfer of its Tampa location, a move designed to raise the standard for the patient experience. The new space increases production capacity and introduces a reimagined front lobby that reflects Strive's patient-first approach, warm, transparent, and service-oriented. The Tampa site strengthens Strive's presence in the Southeast, enabling faster fulfillment, improved service levels, and expanded therapeutic reach.
"Every investment we make, whether it's infrastructure, technology, or talent, is about keeping our brand promise to patients and providers," said Mike Walker, President and co-founder at Strive Pharmacy. "We're building the systems and capabilities this industry deserves, because people's health depends on it."
These initiatives underscore Strive's commitment to set the standard for quality, innovation, and patient care across the nation. The company continues to invest in breakthrough technologies, recruit top-tier talent, and strengthen its operations so that patients and providers always have access to the highest quality care and compounds.
"At Strive, we're not just expanding-we're evolving," added Walker. "We're setting a new benchmark for what it means to serve patients with excellence, transparency, and compassion."
About Strive Pharmacy:
Strive Pharmacy is on a mission to make personalized medicine mainstream. With a strong focus on quality, customization, and a commitment to putting people over profit, Strive Compounding Pharmacy is redefining what personalized healthcare can look like-one prescription at a time. Whether through brick-and-mortar partnerships or innovative telehealth collaborations, Strive Compounding Pharmacy continues to push the boundaries of what's possible in modern medicine. For more information, visit Strive Compounding Pharmacy's website at https://www.strivepharmacy.com/.
Media Contact:
Zach Shurtleff
Chief Marketing Officer
[email protected]
www.strivepharmacy.com
SOURCE: Strive Pharmacy
View the original press release on ACCESS Newswire
N.Walker--AT

